Chaudhary E. Ahmad

463 total citations
5 papers, 56 citations indexed

About

Chaudhary E. Ahmad is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chaudhary E. Ahmad has authored 5 papers receiving a total of 56 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Pathology and Forensic Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chaudhary E. Ahmad's work include Colorectal Cancer Treatments and Studies (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Genetic factors in colorectal cancer (2 papers). Chaudhary E. Ahmad is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Genetic factors in colorectal cancer (2 papers). Chaudhary E. Ahmad collaborates with scholars based in Canada, United States and Pakistan. Chaudhary E. Ahmad's co-authors include Setareh Samimi, Eric Xueyu Chen, Scott R. Berry, Benoît Samson, F. Aubin, Derek J. Jonker, Petr Kavan, Mohammed Harb, Hagen F. Kennecke and Sheryl Koski and has published in prestigious journals such as Journal of Clinical Oncology and Cureus.

In The Last Decade

Chaudhary E. Ahmad

4 papers receiving 55 citations

Peers

Countries citing papers authored by Chaudhary E. Ahmad

Since Specialization

Citations

This map shows the geographic impact of Chaudhary E. Ahmad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaudhary E. Ahmad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaudhary E. Ahmad more than expected).

Fields of papers citing papers by Chaudhary E. Ahmad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chaudhary E. Ahmad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaudhary E. Ahmad. The network helps show where Chaudhary E. Ahmad may publish in the future.

Co-authorship network of co-authors of Chaudhary E. Ahmad

This figure shows the co-authorship network connecting the top 25 collaborators of Chaudhary E. Ahmad. A scholar is included among the top collaborators of Chaudhary E. Ahmad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chaudhary E. Ahmad. Chaudhary E. Ahmad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Audit of Postoperative Complications and Conversion Rate in Laparoscopic Cholecystectomy 2025 ·Cureus ·Haji Muhammad Shoaib Khan, (unknown), (unknown), (unknown), (unknown), Chaudhary E. Ahmad, Rabia Khan	0
2	Prevalence and Associated Risk Factors of Acute Pancreatitis in Patients With Gallstones: A Cross-Sectional Study 2025 ·Cureus ·(unknown), (unknown), Muhammad Mansoor, Chaudhary E. Ahmad, (unknown), (unknown), (unknown), (unknown)	1
3	Plasma phosphocreatine (PC) as a predictive biomarker for immune checkpoint inhibition in patients with refractory metastatic colorectal cancer (mCRC): Analysis of the CCTG CO.26 trial. 2023 ·Journal of Clinical Oncology ·(unknown), Jonathan M. Loree, Derek J. Jonker, Hagen F. Kennecke, Scott Berry, Félix Couture, Chaudhary E. Ahmad, John R. Goffin, Petr Kavan, Mohammed Harb, Bruce Colwell, Setareh Samimi, (unknown), Tahir Abbas, Nathalie Aucoin, F. Aubin, Sheryl Koski, Dongsheng Tu, Christopher J. O’Callaghan, Eric Xueyu Chen	1
4	CCTG CO.26 trial: A phase II randomized study of durvalumab (D) plus tremelimumab (T) and best supportive care (BSC) versus BSC alone in patients (pts) with advanced refractory colorectal carcinoma (rCRC). 2019 ·Journal of Clinical Oncology ·Eric Xueyu Chen, Derek J. Jonker, Hagen F. Kennecke, Scott R. Berry, Félix Couture, Chaudhary E. Ahmad, John R. Goffin, Petr Kavan, Mohammed Harb, Bruce Colwell, Setareh Samimi, Benoît Samson, Tahir Abbas, Nathalie Aucoin, F. Aubin, Sheryl Koski, Alice C. Wei, Nadine M Magoski, Dongsheng Tu, Christopher J. O’Callaghan	37
5	CCTG CO.26: Updated analysis and impact of plasma-detected microsatellite stability (MSS) and tumor mutation burden (TMB) in a phase II trial of durvalumab (D) plus tremelimumab (T) and best supportive care (BSC) versus BSC alone in patients (pts) with refractory metastatic colorectal carcinoma (rmCRC). 2019 ·Journal of Clinical Oncology ·Eric Xueyu Chen, Derek J. Jonker, Jonathan M. Loree, Hagen F. Kennecke, Scott R. Berry, Félix Couture, Chaudhary E. Ahmad, John R. Goffin, Petr Kavan, Mohammed Harb, Bruce Colwell, Setareh Samimi, Benoît Samson, Tahir Abbas, Nathalie Aucoin, F. Aubin, Sheryl Koski, Alice C. Wei, Dongsheng Tu, Christopher J. O’Callaghan	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact